Executive Compensation at the Leukemia and Lymphoma Society (2018)
The Leukemia and Lymphoma Society is a non-profit 501 (c) (3) based in Rye Brook, New York with 1,291 employees who received total compensation of $104 million, which equates to an average of $81,000 per individual. However, the IRS Form 990 (for the year ending June 30, 2018) reports that 187 individuals received more than $100,000 in compensation.
The most highly compensated individuals (12) were compensated $4.6 million (an average of $383,000 each):
- $673,287: Louis J Degennaro, President and CEO
- $401,050: Rosemarie A Loffredo, EVP and CFO
- $399,533: Gwen Nichols, EVP Chief Med Officer
- $395,704: Andrew S Coccari, EVP, Chief Prod Officer
- $372,089: Lee M Greenberger, SVP, Chief Science Officer
- $368,709: Claude Edkins, VP Information Tech (end 3/31/2017)
- $393,076: Alice O’Rourke, EVP, Chief Development Officer
- $359,217: Kathy Grisenbeck, EVP, Chief Res Officer
- $308,604: Gordon Miller, Jr, SVP, Finance
- $297,247: Marcie Klein, EVP, Communications
- $283,803: Elisa Weiss, SVP, Patient Access
- $282,043: Carson Jacobi, SVP Healthcare Part
6 of the 12 most highly compensated individuals are male while 6 are female.
Severance payments of $220,000 (included above) were made to Claude Edkins.
Caitlin Proctor, daughter of a board member, received $29,239 in compensation (from 8/2017-3/2018 as an employee)
146 independent contractors received more than $100,000 in compensation with the five most highly compensated being:
- $7.6 million: INC Research of Chicago, Illinois for clinical trial
- $6.6 million: Patient Advocacy Foundation of Hampton, Virginia for patient assistance procedures
- $6.1 million: Resource One of Tulsa, Oklahoma for direct marketing
- $3.9 million: TargetCW of San Diego, California for temp staffing
- $2.9 million: Northgate Digital Corporation of Newtown, Pennsylvania for software development
To read the IRS Form 990 (2017) for the year ending June 30, 2018, click here.